DAT 582
Alternative Names: AS-5820Latest Information Update: 04 Aug 1998
At a glance
- Originator Dainippon Pharmaceutical
- Class Antiemetics
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Nausea and vomiting
Most Recent Events
- 04 Aug 1998 Discontinued-II for Emesis in Japan (IV)
- 29 Dec 1994 Phase-II clinical trials for Emesis in Japan (IV)